Who owns the AVIDIMAB trademark?

The AVIDIMAB trademark is owned by Scancell Limited.

What class is the AVIDIMAB trademark registered in?

The AVIDIMAB trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for AVIDIMAB?

The USPTO serial number for AVIDIMAB is 90030932.

What is the registration number for AVIDIMAB?

AVIDIMAB is registered under USPTO registration number 6368318.

Sealvo

Home Search: AVIDIMABAVIDIMAB #90030932

Back

Updated Oct 2, 2026·12 searches this week

View on USPTO TSDR Find similar marks

AVI

USPTO Trademark Record

REGISTERED

AVIDIMAB

SN 90030932·Reg 6368318·Filed Jul 01, 2020

Owner Scancell Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AVIDIMAB (Serial No. 90030932), Registration No. 6368318, is a registered US trademark filed on Jul 01, 2020 by Scancell Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Renewal window: June 01, 2027241 days remaining

Conflict Analysis

Full conflict analysis for AVIDIMAB (SN 90030932) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

AVIDIMAB (Reg. #6368318) is a registered US trademark that has been protecting its owner, Scancell Limited, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 01, 2020

SERIAL

90030932

REG#

6368318

REGISTERED

Jun 01, 2021

Filing Information

StatusREGISTERED

Filing DateJul 01, 2020

Serial Number90030932

Registration No.6368318

Registration DateJun 01, 2021

Status DateJun 01, 2021

Published for OppositionMar 16, 2021

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 01, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 19, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 19, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 19, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jan 19, 2023

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 19, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 19, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Jun 01, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 16, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 16, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 24, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 08, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 05, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 05, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 04, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 02, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Oct 07, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 07, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 07, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 06, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 30, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 04, 2020

NEW APPLICATION ENTERED

Other Marks by Scancell Limited

Additional USPTO filings from the same owner.

IMM

IMMUNOBODY

98261434

Scancell Limited

REGISTERED

MOD

MODITOPE

98107336

Scancell Limited

REGISTERED

GLY

GLYMAB

97289101

Scancell Limited

REGISTERED

SCA

SCANCELL

88486481

Scancell Limited

REGISTERED

Other Marks by Andrew D. Price

Additional USPTO filings handled by the same attorney of record.

WOR

WORLD PHARMACY COUNCIL

99461272

REGISTERED

JAT

JAT-EP

99114214

REGISTERED

JAT

JAT-EP

99114237

REGISTERED

SIA

86047889

REGISTERED

AVIDIMAB

Run a conflict check

Other Marks by Scancell Limited

Other Marks by Andrew D. Price

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company